Alwazzan, Ahmad, et al. “Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction”. World Journal of Oncology, vol. 17, no. 5, Jan. 2026, pp. 676-82, https://doi.org/10.14740/wjon2800.